China’s biopharmaceutical industry has experienced an unprecedented growth in recent years, not only catching up with technology but also leading the way in innovation. This transformation is symbolized by a red-and-white capsule, representing breakthrough efficacy and new hope for patients.
Several Chinese pharmaceutical companies are now pioneering the treatment of critical illnesses such as cancer and heart disease. They are filling clinical gaps and providing lifelines to countless patients through their innovative drugs. The featured companies on this cover – Hengrui, BeOne, RemeGen, 3SBio, Akeso, and Hutchmed – are at the forefront of this medical revolution.
These companies are using cutting-edge technologies like immunotherapy, targeted treatments, and antibody drugs to break through technical barriers and gain a foothold on the global stage. This innovation is bringing hope to patients worldwide, as it knows no borders and transcends geographical limitations.
Source: https://oncodaily.com/voices/norman-ng-348474